4

PRIMARY DOCUMENT

Company: INTERPACE BIOSCIENCES, INC.
Filed: January 31, 2020
Period of Report: January 29, 2020
Accession Number: 0001192482-20-000076

View Document ↗ View on SEC.gov ↗